The Berlin-based company Thryve, a spin-off of the Fraunhofer Institute was founded in 2017 as a technology startup and has since been intensively involved in the collection of health data from patients who wear wearables, fitness trackers or other connected medical devices to record their health-related data.
The startup Thryve collects the data via clinical questionnaires, known as ePRO questionnaires, which are then made available to clinical research according to the highest data protection and data security standards, pseudonymized and DSGVO-compliant.
In studies, the daily life of more than 300 patients is analyzed via the wearing of medical sensors to obtain an automatic and passive collection of health data 24 hours a day, seven days a week and at home from the study participant. Thryve’s new technological solution via a smartphone app thus enables the collection of health-related data for integration, processing and analysis via networked health sensors, which include blood pressure monitors and microbiome and blood tests. Disease progression, such as in diabetics and people with rheumatic episodes, can be better assessed in this way. Conclusions for the care and therapies of those affected are thus ideally possible.
Modern healthcare research clearly benefits from Thryve’s new technological achievement, which is possible without Google and Apple connectivity. A unified Thryve data platform brings together patient data in real-time monitoring.
The innovation is already in use by some digital health services, telemedicine providers and health insurance companies such as AOK and Techniker Krankenkasse (depression therapy), but is also now being applied by the Robert Koch Institute (RKI) to use constant, passive health monitoring of 500,000 data donors in the Corona pandemic. In this effort, the RKI’s „Corona Data Donation 2.0“ project is collecting health data from people with or after COVID-19 infection.
In addition, Berlin’s Charité University Hospital and the Institute for Applied Health Services Research are now working with the young company Thryve to benefit equally from the clinical research results.
Source: www.e-health-com.de